Improvement of cardiac function and β-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction

Coronary Artery Disease

Volumn 15, Issue 1, 2004, Pages 65-71

  Sethi, Rajat ^a,b   Wang, Xi ^a,b   Ferrari, Roberto ^c   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

adrenergic signal transduction; adrenoceptor density; Congestive heart failure; Guanine nucleotide binding proteins; Metabolic therapy; Myocardial infarction; Propionyl L carnitine

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; FLUORIDE SODIUM; FORSKOLIN; GUANYLYLIMIDODIPHOSPHATE; ISOPRENALINE; PROPIONYLCARNITINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOTONIC AGENTS; CARNITINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HEART FAILURE, CONGESTIVE; ISOPROTERENOL; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STROKE VOLUME; VENTRICULAR FUNCTION;

EID: 4344718549     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200402000-00010     Document Type: Article

References (50)

1. Homcy CJ, Vatner SF, Vainer DE. β-adrenergic receptor regulation in the heart in pathophysiological states: abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol 1991; 53:137-159.
2. Sethi R, Dhalla NS. Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. J Cardiac Failure 1995; 5:391-399.
3. Böhm M, Diet F, Feiler G, Kemkes B, Erdmann E. α-adrenoceptor and α-adrenoceptor mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 1988; 12:357-364.
4. Newman WH. A depressed response of left ventricular contractile force to isoproterenol and norepinephrine in dogs with congestive heart failure. Am Heart J 1977; 93:216-221.
5. Sethi R, Dhalla KS, Beamish RE, Dhalla NS. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol 1997; 272:H884-H893.
6. Longabaugh J, Vatner DE, Vatner SF, Homcy CJ. Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure overload left ventricular failure. J Clin Invest 1988; 81:420-424.
7. Dhalla NS, Wang X, Sethi R, Das PK, Beamish RE. β-adrenergic linked signal transduction mechanisms in failing hearts. Heart Fail Rev 1997; 2:55-65.
8. Wang X, Dhalla NS. Modification of β-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem 2000; 214:131-155.
9. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 2003; 34:89-99.
10. Marin-Garcia J, Goldenthal MJ. Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovasc Res 2002; 54:516-527.
11. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984; 55:135-154.
12. Shug AL, Subrabanian R. Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z Kardiol 1987; 76:26-33.
13. Siliprandi N, Di Lisa F, Pivetta A, Miotto G, Siliprandi D. Transport and function of L-carnitine and L-propionyl carnitine: relevance to some cardiomyopathies and cardiac ischemia. Z Kardiol 1987; 76:34-40.
14. Yang XP, Samaja M, English E. Hemodynamic and metabolic activities of propionyl L-carnitine in rats with pressure overload cardiac hypertrophy. J Cardiovasc Pharmacol 1992; 20:88-98.
15. Micheletti R, Giacalone G, Caneperi M. Propionyl L-carnitine prevents mechanical alterations due to pressure overload in rats. Am J Physiol 1994; 266:H2190-H2197.
16. Sethi R, Dhalla KS, Ganguly PK, Ferrari R, Dhalla NS. Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction. Cardiovasc Res 1998; 42:607-615.
17. Micheletti R, Di Paola ED, Schiavone A. Propionyl carnitine limits chronic ventricular dilation after myocardial infarction in rats. Am J Physiol 1993; 264:H111-H117.
18. Li P, Park C, Micheletti R. Myocyte performance during evolution of myocardial infarction in rats: Effects of propionyl L-carnitine. Am J Physiol 1995; 268:H1702-H1713.
19. Vargiu R, Licheri D, Carcassi AM, Naimi S, Collu M, Littarru GP, et al. Enhancement of muscular performance by a coformulation of propionyl L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid in the rat. Physiol Behav 2002; 76:257-263.
20. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, et al. L-Propionyl carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 2000; 16:99-104.
21. Ferrari R, de Giuli F. The propionyl L-carnitine hypothesis: an alternative approach to treating heart failure. J Cardiac Fail 1997; 3:217-224.
22. Goldman S, Raya TE. Rat infarct model of myocardial infarction and heart failure. J Cardiac Fail 1995; 1:169-177.
23. Sethi R, Elimban V, Chapman D, Dixon IM, Dhalla NS. Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 1998; 30:2153-2163.
24. Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsuts H, et al. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ Res 2002; 90:959-965.
25. Gealekman O, Abassi Z, Rubinstein I, Winaver J, Binah O. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 2002; 105:236-243.
26. s in septic rabbits. Anesthesiology 2000; 93:1465-1473.
27. Hermann HP, Zeitz O, Lehnart SE, Keweloh B, Datz N, Hasenfuss G, et al. Potentiation of beta-adrenergic inotropic response by pyruvate in failing human myocardium. Cardiovasc Res 2002; 53:116-123.
28. 2+ content in blunted inotropic responsiveness of failing human myocardium. J Mol Cell Cardiol 2002; 34:455-467.
29. Squires JE, Sun J, Caffrey JL, Yoshishige D, Mallet RT. Acetoacetate augments β-adrenergic inotropism of stunned myocardium by an antioxidant mechanism. Am J Physiol 2003; 284:1340-1347.
30. Broderick TL, Driedzic W, Paulson DJ. Propionyl L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat. Mol Cell Biochem 2000; 206:151-157.
31. Micheletti R, Giacalone G, Bianchi G. Effect of propionyl L-carnitine on the mechanics of right and left papillary muscles from volume overload rat hearts. J Cardiovasc Pharmacol 1996; 27:52-57.
32. Terada R, Matsubara T, Koh N, Nakamura J, Hotta N. Effects of propionyl L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats. Eur J Pharmacol 1998; 18:185-191.
33. Guo X, Chapman D, Dhalla NS. Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by imidapril or losartan. Mol Cell Biochem 2003 (in press).
34. Chen LA, Vatner DE, Vatner SF, Hittinger L, Homcy CJ. Decreased Gs mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses. J Clin Invest 1991; 87:293-298.
35. i in cardiac hypertrophy due to acquired hypertension. Hypertension 1992; 20:103-112.
36. Anand-Srivastava MB. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously hypertensive rats. Biochem Pharmacol 1988; 37:3017-3022.
37. Alam SQ, Alam BS, Ren YF. Adenylate cyclase activity, membrane fluidity and fatty acid composition of rat heart in essential fatty acid deficiency. J Mol Cell Cardiol 1987; 19:465-475.
38. Haugland B, Louis RP, Musch SL, Waldeck N, Williams MA. Liver plasma membranes from essential fatty acids deficient rats. Isolation, fatty acid composition, and activities of 5-nucleotidase, ATPase and adenylate cyclase. Biochem Biophys Acta 1976; 433:150-163.
39. Dhalla NS, Kolar F, Shah KR, Ferrari R. Effects of some L-carnitine derivatives on heart membrane ATPases. Cardiovasc Drugs Ther 1991; 5:25-30.
40. Bevilacqua M, Vago M, Norbiato G. Effect of propionyl L-carnitine in L-type calcium channels in human sarcolemma. Cardiovasc Drugs Ther 1991; 1:31-35.
41. Liedtke AJ, Nellis SH, Neely JR. Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemia myocardium in swine. Circ Res 1978; 43:652-661.
42. Liedtke AJ, Nellis SH, Mjos OD. Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts. Am J Physiol 1984; 247:H387-H3394.
43. McCormack JG, Stanley WC, Wolff AA. Pharmacology of ranolazine: a novel metabolic inhibitor for the treatment of angina. Gen Pharmacol 1998; 30:639-645.
44. Katz AM. Mechanisms and abnormalities of contractility and relaxation in the failing heart. Cardiologia 1993; 38:39-43.
45. Paolisso G, Gambardella A, Galzerano D, D'Amore A, Rubino P, Verza M, et al. Total body and myocardial substrate oxidation in congestive heart failure. Metabolism 1994; 43:174-179.
46. el Alaoui-Talibi Z, Guendouz A, Moravec M, Moravec J. Control of oxidative metabolism in volume overloaded rat hearts: effects of propionyl L-carnitine. Am J Physiol 1997; 272:H1615-H1624.
47. Torielli L, Cinti F, Cinato E. Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl I-carnitine. J Cardiovasc Pharmacol 1995; 26:372-380.
48. Stanley WC, Hoppel CL. Mitochondrial dysfunction in heart failure: potential for therapeutic interventions. Cardiovasc Res 2000; 45:805-806.
49. Felix C, Gillis M, Driedzic WR, Paulson DJ, Broderick TL. Effects of propionyl L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diab Res Clin Prac 2001; 53:17-24.
50. Schonekess BO, Allard MF, Lopaschuk GD. Propionyl-L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 1995; 77:726-734.